LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 171 filers reported holding LEGEND BIOTECH CORP in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $665,789 | -43.2% | 9,912 | -41.6% | 1.40% | -23.1% |
| Q2 2023 | $1,172,267 | +35.7% | 16,982 | -5.2% | 1.82% | +43.9% |
| Q1 2023 | $863,620 | -13.5% | 17,910 | -10.5% | 1.26% | -0.9% |
| Q4 2022 | $998,849 | -13.1% | 20,009 | -28.9% | 1.27% | +12.8% |
| Q3 2022 | $1,149,000 | -25.8% | 28,150 | -0.1% | 1.13% | -20.7% |
| Q2 2022 | $1,549,000 | -16.3% | 28,172 | -44.7% | 1.42% | +41.7% |
| Q1 2022 | $1,851,000 | -36.8% | 50,928 | -19.0% | 1.00% | -1.2% |
| Q4 2021 | $2,929,000 | +73.0% | 62,849 | +87.6% | 1.02% | +79.7% |
| Q3 2021 | $1,693,000 | – | 33,493 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |